|
|
| Cancer Antigen-Breast (CA 15-3) | ||
| Order Code: CA153
Order Form: A-1a Miscellaneous Request or IPR Req |
Commercial "Mail-out" Laboratory 6240 RCP 356-3527 |
|
Specimen |
Serum | ||
Collection Medium: |
| ||
Alternate Collection Media: |
Light Green top tube (Lithium Heparin), Green top tube (Na Heparin), Lavender top tube (EDTA) | ||
Minimum: |
Adult recommended volume: 1.0 mL serum Adult absolute minimum: 0.5 mL serum Pediatric absolute minimum: 0.2 mL serum | ||
Analytic Time: |
4 days | ||
Reference Range: |
0 - 31 U/mL | ||
Test Limitations: |
The Roche Modular E170 CA 15-3 electrochemiluminescent immunoassay is used. Results obtained with different methods or kits cannot be used interchangeably. The CA 15-3 assay is used to aid in the management of Stage II and III breast cancer patients. Serial testing for patient CA 15-3 assay values should be used in conjunction with other clinical methods for monitoring breast cancer. Patients with confirmed breast carcinoma frequently have CA 15-3 assay values in the same range as healthy individuals. Elevations may be observed in patients with nonmalignant disease. For these reasons a CA 15-3 assay value, regardless of level, should not be interpreted as absolute evidence of the presence or absence of malignant disease. | ||
Methodology: |
Electrochemiluminescent Immunoassay | ||
CPT Code: |
86300 |
Updated: 03/11/2008
Note: The information contained in this handbook is for use by personnel of University of Iowa Health Care. No other use is implied or intended.